A Photoswitchable Inhibitor of the Human Serotonin Transporter
Abstract
The human serotonin transporter (hSERT) terminates serotonergic signaling through reuptake of neurotransmitter into presynaptic neurons and is a target for many antidepressant drugs. We describe here the development of a photoswitchable hSERT inhibitor, termed azo-escitalopram, that can be reversibly switched between trans and cis configurations using light of different wavelengths. The dark-adapted trans isomer was found to be significantly less active than the cis isomer, formed upon irradiation.
Copyright and License
Copyright © 2020 American Chemical Society
Acknowledgement
We are grateful to Simon Ravnkilde Sinning for designing and producing custom 3D-printed plastic polymer masks enabling controlled illumination of desired wells in microplates. We thank Grace Pan for assistance with the glutathione assay.
Funding
J.M. thanks the German Academic Scholarship Foundation for a fellowship and New York University for a MacCracken fellowship and a Margaret and Herman Sokol fellowship. This work was supported by the National Institutes of Health (Grant R01NS108151-01).
Additional Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acschemneuro.9b00521.
-
Synthetic procedures and analytical data for new compounds; GSH reduction assay results; molecular docking results (PDF)
Files
Name | Size | Download all |
---|---|---|
md5:b174d9556ee59117444a69018253fcf3
|
796.3 kB | Preview Download |
Additional details
- ISSN
- 1948-7193
- National Institute of Neurological Disorders and Stroke
- R01NS108151-01
- German National Academic Foundation
- New York University
- Available
-
2020-04-10Published online
- Publication Status
- Published